Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

63.24 

-0.10 -0.2%

as of Sep 18 '19

52 Week Range:

55.00 91.74


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2018, it operated 3,928 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 14.31
14.97
17.60
18.76
21.92
21.77
24.80
28.03
30.83
31.55
36.55
growth rate 4.6% 17.6% 6.6% 16.8% -0.7% 13.9% 13.0% 10.0% 2.3% 15.9%
Earnings BIT 1,056.46
1,151.06
1,292.98
1,403.35
1,521.61
2,230.09
2,229.70
2,154.23
2,336.72
2,269.48
2,155.45
growth rate 9.0% 12.3% 8.5% 8.4% 46.6% 0.0% -3.4% 8.5% -2.9% -5.0%
Avg.PE 16.86
17.73
17.42
19.08
35.34
19.38
21.17
22.81
19.37
22.86
10.43
growth rate 5.2% -1.8% 9.5% 85.2% -45.2% 9.2% 7.8% -15.1% 18.0% -54.4%
ROA 5.75
5.72
6.16
5.92
5.62
4.78
4.56
4.25
4.83
5.16
7.89
growth rate -0.5% 7.7% -3.9% -5.1% -15.0% -4.6% -6.8% 13.7% 6.8% 52.9%
ROE 14.50
13.76
14.28
14.20
13.97
11.96
11.89
11.20
12.24
12.74
18.37
growth rate -5.1% 3.8% -0.6% -1.6% -14.4% -0.6% -5.8% 9.3% 4.1% 44.2%
ROIC 10.06
9.43
9.87
9.25
9.26
7.99
7.82
7.34
8.23
8.71
12.18
growth rate -6.3% 4.7% -6.3% 0.1% -13.7% -2.1% -6.1% 12.1% 5.8% 39.8%
Cur. Ratio 1.34
1.81
1.36
1.34
1.93
1.77
1.93
1.67
1.45
1.20
1.25
growth rate 35.1% -24.9% -1.5% 44.0% -8.3% 9.0% -13.5% -13.2% -17.2% 4.2%
Quick Ratio 0.82
1.10
0.85
0.79
1.29
1.22
1.39
1.19
1.06
0.88
0.96
growth rate 34.2% -22.7% -7.1% 63.3% -5.4% 13.9% -14.4% -10.9% -17.0% 9.1%
Leverage 2.50
2.32
2.32
2.47
2.50
2.50
2.69
2.58
2.49
2.45
2.23
growth rate -7.2% 0.0% 6.5% 1.2% 0.0% 7.6% -4.1% -3.5% -1.6% -9.0%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 1,710.46
2,017.36
3,016.00
3,313.00
3,535.00
3,653.36
4,028.01
3,827.10
4,139.25
3,696.15
3,765.57
growth rate 17.9% 49.5% 9.9% 6.7% 3.4% 10.3% -5.0% 8.2% -10.7% 1.9%
Acct.Payable 543.00
653.00
746.00
666.53
713.92
718.97
839.63
631.02
702.90
growth rate 20.3% 14.2% -10.7% 7.1% 0.7% 16.8% -24.9% 11.4%
Cur.Assets 3,063.39
3,727.40
5,153.00
5,695.00
6,127.00
6,286.72
6,718.21
6,232.05
6,883.95
6,374.31
7,846.89
growth rate 21.7% 38.3% 10.5% 7.6% 2.6% 6.9% -7.2% 10.5% -7.4% 23.1%
Total Assets 10,851.10
12,473.51
17,095.00
19,533.00
22,326.00
23,119.91
25,380.98
23,355.06
25,503.54
24,025.22
26,242.27
growth rate 15.0% 37.1% 14.3% 14.3% 3.6% 9.8% -8.0% 9.2% -5.8% 9.2%
Cash 161.17
237.47
523.00
457.00
688.00
682.78
633.86
505.95
708.88
978.11
2,145.63
growth rate 47.3% 120.2% -12.6% 50.6% -0.8% -7.2% -20.2% 40.1% 38.0% 119.4%
Inventory 514.27
647.83
809.00
967.00
1,037.00
1,097.10
1,115.55
1,234.50
1,337.48
1,290.78
1,466.80
growth rate 26.0% 24.9% 19.5% 7.2% 5.8% 1.7% 10.7% 8.3% -3.5% 13.6%
Cur.Liabilities 2,286.92
2,057.49
3,790.00
4,263.00
3,170.00
3,553.97
3,477.29
3,820.60
5,298.90
5,299.89
6,268.28
growth rate -10.0% 84.2% 12.5% -25.6% 12.1% -2.2% 9.9% 38.7% 0.0% 18.3%
Liabilities 6,514.72
7,210.71
9,291.00
11,061.00
12,595.00
12,986.64
14,527.95
12,744.00
14,452.41
13,197.03
13,340.31
growth rate 10.7% 28.9% 19.1% 13.9% 3.1% 11.9% -12.3% 13.4% -8.7% 1.1%
LT Debt 2,878.22
3,490.96
4,383.00
5,496.00
7,848.00
7,751.31
9,018.94
7,231.98
6,801.74
5,767.02
5,018.76
growth rate 21.3% 25.6% 25.4% 42.8% -1.2% 16.4% -19.8% -6.0% -15.2% -13.0%
Equity 4,336.38
5,262.81
5,816.26
6,229.62
7,050.27
9,234.56
9,443.31
9,103.59
9,977.66
9,820.10
11,758.41
growth rate 21.4% 10.5% 7.1% 13.2% 31.0% 2.3% -3.6% 9.6% -1.6% 19.7%
Common Shares 298.00
298.00
302.00
305.00
307.00
304.00
303.00
305.00
307.00
308.00
307.00
growth rate 0.0% 1.3% 1.0% 0.7% -1.0% -0.3% 0.7% 0.7% 0.3% -0.3%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 489.84
443.00
524.00
598.00
675.00
747.94
931.63
858.89
930.52
944.46
1,057.28
growth rate -9.6% 18.3% 14.1% 12.9% 10.8% 24.6% -7.8% 8.3% 1.5% 12.0%
Cash Dividends 183.57
182.83
270.82
323.40
214.21
296.13
317.90
236.77
244.25
293.97
324.84
growth rate -0.4% 48.1% 19.4% -33.8% 38.3% 7.4% -25.5% 3.2% 20.4% 10.5%
Cash From OA 739.23
1,055.35
1,368.00
1,446.00
2,039.00
2,034.81
1,861.39
1,766.60
1,931.97
2,191.81
2,061.91
growth rate 42.8% 29.6% 5.7% 41.0% -0.2% -8.5% -5.1% 9.4% 13.5% -5.9%
FCF per Share 0.75
1.38
2.33
1.79
3.39
3.03
2.42
3.12
2.39
5.20
2.29
growth rate 84.0% 68.8% -23.2% 89.4% -10.6% -20.1% 28.9% -23.4% 117.6% -56.0%
Sale Purchase of Stock 146.08
107.05
94.17
49.07
47.59
growth rate -26.7% -12.0% -47.9% -3.0%
FCF 236.00
534.00
635.00
655.00
1,031.00
932.00
765.00
921.00
1,055.00
1,247.00
1,005.00
growth rate 126.3% 18.9% 3.2% 57.4% -9.6% -17.9% 20.4% 14.6% 18.2% -19.4%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 7,718.33
8,867.53
12,053.00
12,795.00
14,081.00
14,894.38
16,134.26
15,454.86
16,569.72
17,783.57
16,546.87
growth rate 14.9% 35.9% 6.2% 10.1% 5.8% 8.3% -4.2% 7.2% 7.3% -7.0%
Op.Income 1,216.34
1,384.12
1,065.00
1,177.00
1,327.00
2,230.09
2,229.70
2,154.23
2,336.72
2,269.48
2,155.45
growth rate 13.8% -23.1% 10.5% 12.7% 68.1% 0.0% -3.4% 8.5% -2.9% -5.0%
IBT 971.45
1,147.60
1,295.89
1,402.09
1,523.27
1,847.64
1,843.41
1,775.68
2,045.49
1,997.62
2,736.74
growth rate 18.1% 12.9% 8.2% 8.6% 21.3% -0.2% -3.7% 15.2% -2.3% 37.0%
Net Income 594.64
702.54
1,065.00
1,177.00
1,327.00
1,109.89
1,045.27
954.95
1,143.98
1,279.79
1,981.92
growth rate 18.2% 51.6% 10.5% 12.7% -16.4% -5.8% -8.6% 19.8% 11.9% 54.9%
EPS 1.97
2.09
2.44
2.71
2.93
2.64
2.84
3.13
3.73
4.16
6.45
growth rate 6.1% 16.8% 11.1% 8.1% -9.9% 7.6% 10.2% 19.2% 11.5% 55.1%
Gross Profit 2,639.23
3,020.75
4,044.00
4,377.00
4,882.00
5,023.05
5,298.49
5,177.17
5,615.95
6,018.25
5,154.74
growth rate 14.5% 33.9% 8.2% 11.5% 2.9% 5.5% -2.3% 8.5% 7.2% -14.4%
R&D 58.33
73.95
76.08
87.35
87.99
125.81
122.11
128.13
146.51
130.70
133.62
growth rate 26.8% 2.9% 14.8% 0.7% 43.0% -2.9% 4.9% 14.4% -10.8% 2.2%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 551.42
498.93
613.03
516.52
487.38
growth rate -9.5% 22.9% -15.7% -5.6%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 3,687.36
3,486.92
3,765.57
3,952.17
3,654.72
growth rate -5.4% 8.0% 5.0% -7.5%
Acct.Payable 741.44
804.88
702.90
824.38
765.38
growth rate 8.6% -12.7% 17.3% -7.2%
Cur.Assets 7,511.57
7,533.65
7,846.89
7,500.85
7,167.08
growth rate 0.3% 4.2% -4.4% -4.5%
Total Assets 25,044.93
25,587.09
26,242.27
32,353.20
31,956.00
growth rate 2.2% 2.6% 23.3% -1.2%
Cash 1,657.46
1,754.05
2,145.63
958.79
922.10
growth rate 5.8% 22.3% -55.3% -3.8%
Inventory 1,393.59
1,453.75
1,466.80
1,695.66
1,687.49
growth rate 4.3% 0.9% 15.6% -0.5%
Cur.Liabilities 5,495.79
6,051.48
6,268.28
7,363.43
7,221.40
growth rate 10.1% 3.6% 17.5% -1.9%
Liabilities 13,066.63
13,241.24
13,340.31
19,126.70
19,155.55
growth rate 1.3% 0.8% 43.4% 0.2%
LT Debt 5,489.98
5,040.52
5,018.76
5,681.16
5,922.84
growth rate -8.2% -0.4% 13.2% 4.3%
Equity 10,895.53
11,216.48
11,758.41
12,050.59
11,608.05
growth rate 3.0% 4.8% 2.5% -3.7%
Common Shares 308.22
308.94
307.88
307.91
304.34
growth rate 0.2% -0.3% 0.0% -1.2%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 244.42
266.05
325.32
200.85
296.21
growth rate 8.9% 22.3% -38.3% 47.5%
Cash Dividends 324.84
354.64
354.64
354.64
354.64
growth rate 9.2% 0.0% 0.0% 0.0%
Cash From OA 655.64
609.45
841.62
75.56
852.24
growth rate -7.1% 38.1% -91.0% 1,027.9%
Sale Purchase of Stock
growth rate
FCF 411.22
343.40
516.31
-125.29
556.03
growth rate -16.5% 50.4% -100.0% 100.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 4,213.71
4,057.85
4,299.69
4,132.56
4,345.03
growth rate -3.7% 6.0% -3.9% 5.1%
Op.Income 551.42
498.93
613.03
516.52
487.38
growth rate -9.5% 22.9% -15.7% -5.6%
IBT 1,316.80
452.27
550.76
428.70
406.90
growth rate -65.7% 21.8% -22.2% -5.1%
Net Income 993.98
284.61
424.77
270.75
253.78
growth rate -71.4% 49.3% -36.3% -6.3%
EPS
growth rate
Gross Profit 1,304.24
1,267.35
1,380.40
1,265.29
1,330.92
growth rate -2.8% 8.9% -8.3% 5.2%
R&D 37.65
25.74
38.33
33.61
41.02
growth rate -31.6% 48.9% -12.3% 22.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (53.32)

YOY Growth Grade:

C (53.24)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 15.68 15.69 12.62
EPS / Growth 7.4% 4.03 11.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 9.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 7.4% 9.4% 9.4%
Future PE 12.62 15.67 15.67
Future EPS 8.26 9.85 9.85
Value Price
MOS %
25.77
-59.3%
38.16
-39.7%
38.16
-39.7%
MOS Price 12.88 19.08 19.08
IRT 10.24 9.51 9.51

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.